HIV Infection, Antiretroviral Therapy Use and Other Predictors of Selected Clinical Events in Kaiser Permanente
Phase 4
18 Years
N/A
18 Years
N/A
Open (Enrolling by invite only)
Both
HIV, AIDS
Both
HIV, AIDS
Trial Information
HIV Infection, Antiretroviral Therapy Use and Other Predictors of Selected Clinical Events in Kaiser Permanente
All HIV infected patients in the database will be included without any sampling. A random
sample of non-HIV infected patients will be included as comparator.
Inclusion Criteria:
HIV infection.
Exclusion Criteria:
None
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Incidence rate of Malignancies
Outcome Time Frame:
Mean follow up of 4 years
Safety Issue:
Yes
Principal Investigator
Pfizer CT.gov Call Center
Investigator Role:
Study Director
Investigator Affiliation:
Pfizer
Authority:
United States: Investigational Review Board
Study ID:
A4001105
NCT ID:
NCT01339403
Start Date:
September 2008
Completion Date:
September 2013
Related Keywords:
- HIV
- AIDS
Name | Location |
|---|
